Regulation of MHC Class II Expression by Interferon-γ Mediated by the Transactivator Gene CIITA
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Major histocompatibility complex (MHC) class II genes are expressed constitutively in only a few cell types, but they can be induced in the majority of them, in particular by interferon-gamma (IFN-gamma). The MHC class II transactivator gene CIITA is defective in a form of primary MHC class II deficiency. Here it is shown that CIITA expression is controlled and induced by IFN-gamma. A functional CIITA gene is necessary for class II induction, and transfection of CIITA is sufficient to activate expression of MHC class II genes in class II-negative cells in the absence of IFN-gamma. CIITA is therefore a general regulator of both inducible and constitutive MHC class II expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The expression of PD-L1 and MHC II, which may cause exhaustion by binding to T-cell programmed cell death protein 1 (PD-1) and lymphocyte activation gene 3 (LAG-3), respectively, is regulated by tumor interferon (IFN) signaling.”
From Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma (2021) · cites this paper as [27]
Citations
Cites
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor
Schindler, C., Shuai, K., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1496401 · Cited by 899
Steimle, V (1993) · Cell · doi:10.1016/0092-8674(93)90685-j · Cited by 864
A Single Phosphotyrosine Residue of Stat91 Required for Gene Activation by Interferon-γ
Shuai, K., Stark, G. R., Kerr, L. M., & Darnell, J. E. (1993) · Science · doi:10.1126/science.7690989 · Cited by 802
Activation of Transcription by IFN-γ: Tyrosine Phosphorylation of a 91-kD DNA Binding Protein
Shuai, K., Schindler, C., Prezioso, V. R., & Darnell, J. E. (1992) · Science · doi:10.1126/science.1281555 · Cited by 775
Collins, T., Korman, A. J., Wake, C. T., Boss, J. M., Kappes, D. J., Fiers, W., Ault, K. A., Gimbrone, M. A., Strominger, J. L., & Pober, J. S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.15.4917 · Cited by 585
Sequences And Factors: A Guide To Mhc Class-Ii Transcription
Glimcher, L. (1992) · Annual Review of Immunology · doi:10.1146/annurev.immunol.10.1.13 · Cited by 534
Benoist, C., & Mathis, D. (1990) · Annual Review of Immunology · doi:10.1146/annurev.iy.08.040190.003341 · Cited by 457
Müller, M., Laxton, C., Briscoe, J., Schindler, C., Improta, T., Darnell, J. E., Stark, G. R., & Kerr, I. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06106.x · Cited by 411
Detection of a novel human class II HLA antigen
Watson, A. J., DeMars, R., Trowbridge, I. S., & Bach, F. H. (1983) · Nature · doi:10.1038/304358a0 · Cited by 376
Cited by
Items 601–700 of 899
Psifidi, A., Kranis, A., Rothwell, L., Bremner, A., Russell, K., Robledo, D., Bush, S. J., Fife, M. S., Hocking, P. M., Banos, G., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-79005-7 · Cited by 15
Halm, D., Leibig, N., Martens, J., Stark, G. B., Groß, T., Zimmermann, S., Finkenzeller, G., & Lampert, F. M. (2021) · Biological Chemistry · doi:10.1515/hsz-2020-0306 · Cited by 12
Identification of a Nuclear Export Sequence in the MHC CIITA
Chiu, E., Gold, T. M., Fettig, V. M., LeVasseur, M. T., & Cressman, D. E. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402026 · Cited by 13
Huisinga, M., Failing, K., & Reinacher, M. (2007) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2007.05.020 · Cited by 12
Tschickardt, M., Lu, Y., Jacim, M., Ussery, G. D., Steimle, V., Mach, B., & Blanck, G. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620417 · Cited by 12
Effect of interferon alpha on MHC class II gene expression in ex vivo human islet tissue
Harris, P. E., Malanga, D., Liu, Z., Hardy, M. A., Souza, F., Pozzo, G. D., WINCHESTER, R. J., & Maffei, A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.05.001 · Cited by 12
“It is widely accepted that IFNγ induced MHCII expression is controlled by the induction of CIITA [33].”
BackgroundFasolino, M., Schwartz, G. W., Golson, M. L., Wang, Y. J., Morgan, A. R., Liu, C., Schug, J., Liu, J., Wu, M., Traum, D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.28.428598 · Cited by 12
“Although our study represents the first report of ductal cells expressing MHC Class II proteins in the T1D context, this finding is in accordance with previous literature documenting an elevation of immune cells in the exocrine pancreas of T1D donors (5, 27, 45) and regulation of MHC Class II genes by the interferon s…”
ResultCoburn, M., Eskandari‐Sedighi, G., Hasselmann, J., England, W., Shabestari, S. K., Mansour, K., McQuade, A., Mgerian, M., Chadarevian, J. P., Tu, C. H., et al. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70930 · Cited by 15
The role and application of three IFN-related reactions in psoriasis
He, J., Zhao, M., Ma, X., Li, D., Kong, J., & Yang, F. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115603 · Cited by 12
The balance between nuclear import and export of NLRC5 regulates MHC class I transactivation
Zhu, B., Ouda, R., An, N., Tanaka, T., & Kobayashi, K. S. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107205 · Cited by 11
Mohammed, A., Wang, W., Villanueva, M. A., Solomon, B. D., Slepicka, P. F., Hubka, K. M., Nguyen, H. D., Zheng, Z., Chavez, M., Yeh, C. Y., et al. (2025) · Science Immunology · doi:10.1126/sciimmunol.ado4720 · Cited by 11
Chemoresistance in acute myeloid leukemia: An alternative single‐cell RNA sequencing approach
Cheng, P., Hsiao, T., Chen, C., Hung, M., Jhan, P., Lee, L., Wu, T., Tsai, J., & Teng, C. J. (2023) · Hematological Oncology · doi:10.1002/hon.3129 · Cited by 11
“Steimle et al.26 reported that IFN‐γ upregulates MHC class II expression.”
BackgroundZhu, D., Tang, Q., Yu, B., Meng, M., Liu, W., Li, J., Zhu, T., Vanhoutte, P. M., Leung, S. W. S., Zhang, Y., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15237 · Cited by 9
Garg†, S. K., Welsh, E. A., Fang, B., Hernandez, Y., Rose, T. A., Gray, J. E., Koomen, J. M., Berglund, A., Mulé, J. J., & Markowitz, J. (2020) · Cancers · doi:10.3390/cancers12123515 · Cited by 12
“NF-κB expression also leads to the expression of MHC class II genes in response to inflammatory stimuli of IFN-γ [65,66].”
BackgroundGenève, L., Chemali, M., Desjardins, M., Labrecque, N., & Thibodeau, J. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2012.27 · Cited by 11
Day, N., Ugai, H., Yokoyama, K. K., & Ichiki, A. T. (2003) · Leukemia Research · doi:10.1016/s0145-2126(03)00072-9 · Cited by 11
Zhang, C., Hu, S., Zosky, G. R., Wei, X., Shu, S., Wang, D., & Chai, X. (2020) · Shock · doi:10.1097/shk.0000000000001591 · Cited by 11
“presentation, accumulating evidence now indicated that a substantial increase of MHC-II, iNOS, and other pro-inflammatory characteristics were exhibited once macrophages was activated and displayed a pro-inflammatory phenotype in response to different forms of stimulation (22, 23).”
BackgroundLawson, C., McCormack, A. M., Moyes, D. L., Yun, S., Fabre, J. W., Yacoub, M. H., & Rose, M. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.734 · Cited by 11
HLA class II expression in human tumor lines
Blanck, G. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)00226-9 · Cited by 11
Analysis of the Sequence Polymorphism within Class II Transactivator Gene Promoters
Janitz, M., Reiners-Schramm, L., Mühlethaler‐Mottet, A., Rosowski, M., & Lauster, R. (2001) · Experimental and Clinical Immunogenetics · doi:10.1159/000049198 · Cited by 11
Sakamoto, S., Nie, J., & Taniguchi, T. (1999) · PubMed · Cited by 11
Cutaneous dendritic cells in the crossfire between innate and adaptive immunity
Nickoloff, B. J. (2002) · Journal of Dermatological Science · doi:10.1016/s0923-1811(02)00043-9 · Cited by 11
“[31] Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B,”
Fukutani, Y., Kurachi, K., Torisawa, Y., Miyata, K., Hayashi, M., Sasaki, K., Saitoh, K., Watanabe, S., Hasegawa, Y., Naritomi, Y., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04461-9 · Cited by 16
Arakaki, R., Nagaoka, A., Ishimaru, N., Yamada, A., Yoshida, S., & Hayashi, Y. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080695 · Cited by 11
Outcome of rheumatoid arthritis following adjunct statin therapy
Das, S., Mohanty, M., & Padhan, P. (2015) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.169585 · Cited by 10
“[23] Atorvastatin, lovastatin, and pravastatin have been shown to reduce the expression of major histocompatibility complex‐II (MHC‐II) on antigen presenting cells and MHC‐II mediated T‐cell activation.[24] Statins have been suggested to reduce inflammatory cytokines production like tumor necrosis factor‐α and interle…”
BackgroundDylewski, J. F., Tonsawan, P., Garcia, G. E., Lewis, L., & Blaine, J. T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230401 · Cited by 11
SARS-CoV-2 NSP5 antagonizes MHC II expression by subverting histone deacetylase 2
Taefehshokr, N., Lac, A., Vrieze, A. M., Dickson, B. H., Guo, P. N., Jung, C., Blythe, E. N., Fink, C., Aktar, A., Dikeakos, J. D., et al. (2024) · Journal of Cell Science · doi:10.1242/jcs.262172 · Cited by 17
Janelidze, S., Bexell, D., Badn, W., Darabi, A., Smith, K.-E., Fritzell, S., Gunnarsson, S., Milos, P., Bengzon, J., Salford, L. G., et al. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181a95148 · Cited by 11
Beaulieu, Y. B., Machado, J. A. L., Ethier, S. D., Gaudreau, L. R., & Steimle, V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0148753 · Cited by 13
Lahat, N., Rahat, M. A., Sadeh, O., Kinarty, A., & Kraiem, Z. (1998) · Thyroid · doi:10.1089/thy.1998.8.361 · Cited by 10
“Recently, an MHC class II trans-activator (CIITA) was described B cells (45), and proved essential for both the constitutive and inducible expression of class II antigens (46).”
Cutting Edge: Phorbol Ester Induction of IFN-γ Receptors Leads to Enhanced DR α Gene Expression
Sakamoto, S., Nie, J., & Taniguchi, T. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.8.4381 · Cited by 10
Itoh-Lindstrom, Y., Peterlin, B. M., & Ting, J. P. ‐. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.282 · Cited by 10
Diegelmann, J., & Brand, S. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1226809 · Cited by 9
“CIITA is the master regulator of MHCII gene expression (12) and acts as transcriptional coactivator that does not bind DNA itself, but helps to assemble the transcription factor complex necessary for MHCII transcription (13).”
Untangling the genetics of beta cell dysfunction and death in type 1 diabetes
Robertson, C. C., Elgamal, R. M., Henry-Kanarek, B. A., Arvan, P., Chen, S., Dhawan, S., Eizirik, D. L., Kaddis, J. S., Vahedi, G., Parker, S. C. J., et al. (2024) · Molecular Metabolism · doi:10.1016/j.molmet.2024.101973 · Cited by 13
“Finally, although not linked speci fi cally to T1D-associated variants, CIITA, a transcriptional regulator of MHC class II gene expression, represents a fourth potential candidate gene in the 16p13 locus [195,196].”
BackgroundHLA-C expression in extravillous trophoblasts is determined by an ELF3–NLRP2/NLRP7 regulatory axis
Gu, B., Le, G.-H., Herrera, S., Blair, S. J., Meissner, T. B., & Strominger, J. L. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2404229121 · Cited by 10
ZBTB48 is a priming factor regulating B-cell-specific CIITA expression
Rane, G., Kuan, V. L. S., Wang, S., Mok, M. M. H., Khanchandani, V., Hansen, J., Norvaisaite, I., Zulkaflee, N., Yong, W. K., Jahn, A., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00306-y · Cited by 10
“FACS methods or legend for Figure 4 should be improved for more detailed information.”
Yang, Z., Li, F., Huang, Y., Yin, N., Chu, J., Ma, Y., Pettigrew, R. I., Hamilton, D. J., Martin, D., & Li, Z. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263151 · Cited by 10
Structural aspects of the MHC expression control system
Nash, G., Paidimuddala, B., & Zhang, L. (2022) · Biophysical Chemistry · doi:10.1016/j.bpc.2022.106781 · Cited by 15
Erie, A. J., Samsel, L., Takaku, T., Desierto, M. J., Keyvanfar, K., McCoy, J. P., Young, N. S., & Chen, J. (2011) · Experimental Hematology · doi:10.1016/j.exphem.2011.05.005 · Cited by 9
“Because IFN-g stimulates expression of MHC class II [24,25] and Fas [29], we reasoned that IFN-g could also augment MHC class II and Fas expression on BM cell targets, contributing to BM failure.”
Donner, H., Seidl, C., Rau, H., Herwig, J., Seifried, E., Usadel, K. H., & Badenhoop, K. W. J. (2002) · European Journal of Immunogenetics · doi:10.1046/j.1365-2370.2002.00321.x · Cited by 9
Gui-xia, T., Zhou, H.-J., Xu, J.-W., Xu, J., Ji, M., Wu, H.-W., & Wu, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049234 · Cited by 9
Ong, C. E. B., Cheng, Y., Siddle, H. V. T., Lyons, A. B., Woods, G. M., & Flies, A. S. (2022) · Open Biology · doi:10.1098/rsob.220208 · Cited by 8
Wolf, H. M., Thon, V., Gulle, H., Lechleitner, S., Eibl, M. M., & Petzelbauer, P. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03105.x · Cited by 9
“…a mutation of the class II transactivator (CIITA), a nonDNA-binding co-activator that controls constitutive and inducible MHC class II expression (Steimle et al, 1993, 1994), is found in patients belonging to complementation group A, whereas RFXANK, RFX5 and RFXAP, three different protein…”
BackgroundMHC class II‐deficient tumor cell lines with a defective expression of the class II transactivator
Naves, R. F., Lennon, A. M., Barbieri, G., Reyes, L. I., Yung, G. P., Salas‐Cortés, L., Deffrennes, V., Rosemblatt, M. S., Fellous, M., Charron, D. J., et al. (2002) · International Immunology · doi:10.1093/intimm/14.5.481 · Cited by 9
Martínez-Soria, E., Siegrist, C., & Mach, B. (1996) · International Immunology · doi:10.1093/intimm/8.4.543 · Cited by 9
Parsons, B., Medina-Luna, D., Scur, M., Pinelli, M., Gamage, G. S., Chilvers, R. A., Hamon, Y., Ahmed, I. H. I., Savary, S., Makrigiannis, A. P., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.113744 · Cited by 9
Differential Optical Imaging of Antigen Presentation Machinery Using Molecular Optical Reporters
He, S., Yu, J., Cheng, P., Liu, J., Zhang, C., Xu, C., Pu, K., & Zhang, Y. (2025) · Advanced Materials · doi:10.1002/adma.202420393 · Cited by 11
Becker, S. H., Ronayne, C. E., Bold, T. D., & Jenkins, M. K. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013208 · Cited by 15
Chung, D. L., Hou, Z., Wang, Y., Islam, K. A., Liu, S., Liu, J., Chow, L. K.-Y., Wong, Y. Y.-W., Chak, C. P.-T., Zhang, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61597-1 · Cited by 10
“This interaction is suf fi - cient to induce the expression of MHC class II genes in MHC-II-de fi cient cells without interferon-γ stimulation 37 .”
Cytotoxic T Cells: Kill, Memorize, and Mask to Maintain Immune Homeostasis
Kumar, V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188788 · Cited by 16
Hypoimmune stem cells and islets: hype or a true breakthrough in diabetes treatment?
Shalaby, K. E., & Abdelalim, E. M. (2025) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-025-00786-8 · Cited by 12
Brar, H. K., Roy, G., Kanojia, A., Madan, E., Madhubala, R., & Muthuswami, R. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.860058 · Cited by 8
Rossbach, B., Hariharan, K., Mah, N., Oh, S.-J., Volk, H., Reinke, P., & Kurtz, A. (2022) · Cells · doi:10.3390/cells11081328 · Cited by 9
Jeong, H., Lee, H., Kim, H. M., Jang, J., Kim, S., Hwang, T., Choi, D. W.-Y., Kim, H. S., Lee, N., Lee, Y. M., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105358 · Cited by 15
“Furthermore, Pollack et al. (2011) reported that IFNG activates CIITA expression and, subsequently, HLA class II expression.”
InfluentialType I Interferon Regulates the Survival and Functionality of B Cells in Rainbow Trout
Benedicenti, O., Wang, T., Morel, E., Secombes, C. J., Soleto, I., Díaz‐Rosales, P., & Tafalla, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01494 · Cited by 7
“IFNγ also plays an important role in antigen presentation, as it increases MHC II expression and maturation of macrophages and dendritic cells (DCs) (8, 9).”
BackgroundHLA-DRB1 genes and the expression dynamics of HLA CIITA determine the susceptibility to T2DM
Chinniah, R., Sevak, V., Pandi, S., Ravi, P. M., Vijayan, M., Arun, K., & Balakrishnan, K. (2021) · Immunogenetics · doi:10.1007/s00251-021-01212-x · Cited by 9
Dextran Sulfate Inhibits IFN-γ-Induced Jak-Stat Pathway in Human Vascular Endothelial Cells
Lian, R. H., Kotwal, G. J., Hunt, L. A., Wilson, M. A., & Justus, D. E. (1999) · Cellular Immunology · doi:10.1006/cimm.1998.1452 · Cited by 8
Bladon, J., & Taylor, P. C. (2004) · Journal of Cutaneous Medicine and Surgery · doi:10.1007/s10227-004-0102-z · Cited by 8
Åkesson, E., Markling, L., Kjældgaard, A., Falci, S. P., & Ringdén, O. T. H. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00383-0 · Cited by 7
Wagoner, N. J. V., O'Keefe, G. M., & Benveniste, E. N. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00010-1 · Cited by 8
Defective class II transactivator expression in a B lymphoma cell line
Prod’homme, T., Drénou, B., Ruyffelaere, C. D., Barbieri, G., Wiszniewski, W. K., Bastard, C., Charron, D. J., & Alcaïde‐Loridan, C. (2004) · Leukemia · doi:10.1038/sj.leu.2403315 · Cited by 8
Yasumizu, Y., Ohkura, N., Murata, H., Kinoshita, M., Funaki, S., Nojima, S., Kido, K., Kohara, M., Motooka, D., Okuzaki, D., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.19.473411 · Cited by 8
Modulation of recovery from neonatal hyperoxic lung injury by sex as a biological variable
Cantu, A., Gutierrez, M. E. C., Dong, X., Leek, C. C., Anguera, M. C., & Lingappan, K. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102933 · Cited by 8
“Endothelial expression of MHC-II genes may point to their role as antigen-presenting cells to T-cells and furthers the endothelial to immune cell link [57 – 60], with interferon-gamma mediated signaling inducing the expression of MHC class II genes.”
Weisbrod, L., Capriotti, L., Hofmann, M., Spieler, V., Dersch, H., Voedisch, B., Schmidt, P. M., & Knake, S. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1386160 · Cited by 8
“MHC-II molecules are predominantly expressed on professional antigen-presenting cells (APCs) such as dendritic cells, B cells, macrophages, and thymic epithelial cells (16).”
BackgroundToxoplasma Gondii Infection Supports the Infiltration of T Cells into Brain Tumors
Nguyen, Y. T. M., Sibley, L. A., Przanowski, P., Zhao, X., Kovacs, M. A., Wang, S., Jones, M., Cowan, M. N., Liu, W., Merchak, A. R., et al. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578402 · Cited by 8
Ye, K., Yan, Y.-F., Su, R., Dai, Q., Qiao, K., Cao, Y., Xu, J. C., Yan, L., Huo, Z., Liu, W., et al. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00853-w · Cited by 8
IL-1β-mediated suppression of CIITA attenuates IFN-γ-induced MHC-II expression on Fibroblasts
Chen, L., Jiang, H., Tan, B., Geng, R., Chen, J., Wu, S., Zhang, F., Lang, Y., Ma, H., Zheng, X. W., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02575-4 · Cited by 7
“Mechanistically, because CIITA is the master regulator of MHC-II expression downstream of IFN-γ, modulation of IL-1 signaling may influence the abundance or phenotype of MHC-II ⁺ CAF subsets and thereby alter CD4 ⁺ T cell differentiation and Treg recruitment in human tumors [49–51].”
Temporal regulation of human reactive astrocytes reveals their capacity for antigen presentation
Hill, E., Sojka, C., Sampson, M. M., Kebede, N., Wang, H. V., Showrin, S., King, A. T., Sing, A., Chang, J., Faúndez, V., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.02.025 · Cited by 11
Mints, M., Sample, R. A., Parikh, A. S., Zaretsky, J. M., Qi, Z., Law, T. E., Wang, F., Barrett, T. F., Mullins, R. D. Z., Reeb, A. N., et al. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102715 · Cited by 10
Fíoravantí, M. C. S., Freitas, T. M. S., de Moura, M. I., Costa, G. L., Dias, J. M., Guimarães, L., Carpio, M. M. G., & Landi, V. (2020) · Archivos de Zootecnia · doi:10.21071/az.v69i267.5353 · Cited by 7
Enhancement of Th1 type cytokine production and primary T cell activation by PBI-1393
Allam, M., Julien, N., Zacharie, B., Penney, C., & Gagnon, L. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.07.017 · Cited by 9
“IFN-γ is involved in a variety of immune responses including T cell proliferation and differentiation [10,11], monocyte/macrophage activation [4], pro-inflammatory cytokine production (TNF-α ,I L-1β) [12,13], and IFN-γ induced up-regulation of major histocompatibility complex class I and II expression [14, 15 ].”
BackgroundBanu, N., Mozes, M. M., Kopp, J. B., Ziyadeh, F. N., & Meyers, C. M. (2002) · Nephron Experimental Nephrology · doi:10.1159/000065295 · Cited by 7
Repression of MHC determinants in HIV infection
Kanazawa, S., & Peterlin, B. M. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(01)01402-2 · Cited by 7
Downregulation of class II transactivator (CIITA) expression by synthetic cannabinoid CP55,940
Gongora, C., Hose, S., O’Brien, T. P., & Sinha, D. (2003) · Immunology Letters · doi:10.1016/j.imlet.2003.09.006 · Cited by 7
RUEMMELE, Dionne, LEVY, & Seidman (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00532.x · Cited by 7
Cannon, M. J., Davis, J. S., & Pate, J. L. (2006) · Reproduction · doi:10.1530/rep.1.00906 · Cited by 7
“Since previous studies have shown that Ii and DM are coordinately regulated by the class II transactivating factor CIITA (Steimle et al. 1994, Chang & Flavell 1995), this result was unexpected in light of the observed lack of change in Ii mRNA concentration throughout the estrous cycle.”
ResultInterferon αbiology, pharmacology and therapy for chronic viral hepatitis
Dusheiko, G. M. (2003) · Elsevier eBooks · doi:10.1016/b978-012689663-3/50058-2 · Cited by 10
The RAG cell line defines a new complementation group of MHC class II deficiency
Lennon, A., Ottone, C., Peijnenburg, A., Hamon-Benais, C., Colland, F., Gobin, S. J. P., van den Elsen, P. J., Fellous, M., Bono, R., & Alcaïde‐Loridan, C. (1996) · Immunogenetics · doi:10.1007/bf02199803 · Cited by 7
“As cell lines from group A are defective forCIITA, encoded by human chromosome 16 (Steimle et al. 1994), it was essential to ascertain the complementation of RAG with cell lines from complementation group A.”
BackgroundSugawara, M., Scholl, T., Mahanta, S. K., Ponath, P. D., & Strominger, J. L. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.182.1.175 · Cited by 7
“5 cells, a member of complementation group A, was isolated by complementation cloning (18, 19).”
MethodHou, C., Periou, B., Gervais, M., Berthier, J., Baba‐Amer, Y., Souvannanorath, S., Malfatti, E., Relaix, F., Bencze, M., & Authier, F. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.16.472927 · Cited by 7
Estrada, J., Reyes, L. M., Wang, Z., Burlak, C., Gennuso, V. N., Figueroa, O., Levkovitz, C., Vianna, R., Copsel, S. N., Tector, M., et al. (2025) · Transplantation · doi:10.1097/tp.0000000000005385 · Cited by 6
Jackson, S. E., Noor, M., Lim, E. Y., & Wills, M. R. (2025) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2024.0408 · Cited by 10
“Additionally, IFN-γ can induce MHC class II expression in cells that do not constitutively express it, such as epithelial cells and fibroblasts, through activation of the MHC class II transactivator gene (CIITA) [148].”
Pázmány, T., Mechtler, L. L., Tomasi, T. B., Kosa, J. P., Turoczı, A., & Urbányi, Z. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01583-8 · Cited by 6
Pisapia, L., Pozzo, G. D., Barba, P., Citro, A., Harris, P. E., & Maffei, A. (2012) · Results in Immunology · doi:10.1016/j.rinim.2012.09.001 · Cited by 6
Dodiuk‐Gad, R. P., Chung, W., & Shear, N. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-29785-9_25 · Cited by 8
“IFN-γ is also known to promote antigen presentation and thus stimulate the cell-mediated immunity by upregulation of MHC molecules [40] [41] [42] .”
BackgroundHistocompatibility and Reproduction: Lessons from the Anglerfish
Isakov, N. (2022) · Life · doi:10.3390/life12010113 · Cited by 8
Xu, L., Niesen, M. I., & Blanck, G. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.07.035 · Cited by 6
Sun, B., Zhang, X., Wang, G., Kong, Q., Mu, L., Wang, J., Zhang, S., Liu, Y., Li, R., Liu, L., et al. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.042 · Cited by 6
NLRC5/CITA: A Novel Regulator of Class I Major Histocompatibility Complex Genes
Kobayashi, K. S. (2012) · Journal of Immunodeficiency & Disorders · doi:10.4172/2324-853x.1000e102 · Cited by 5
Mishra, G. P., Jha, A., Ahad, A., Sen, K., Sen, A., Podder, S., Prusty, S., Biswas, V. K., Gupta, B., & Raghav, S. K. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04424-w · Cited by 6
Oliver, L., Alvarez, R., Diaz, R., Valdés, A., Colligan, S. H., Nemeth, M. J., Twum, D. Y. F., Fernández, A., Fernández-Medina, O., Carlson, L. M., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004710 · Cited by 6
Waithman, J. C., Moffat, J. M., Patterson, N. L., van Beek, A. E., & Mintern, J. D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.00118-5 · Cited by 7
Mahmoud, M. E., Nikami, H., Shiina, T., Takewaki, T., & Shimizu, Y. (2009) · International Immunopharmacology · doi:10.1016/j.intimp.2009.10.001 · Cited by 6
Ou, Q., Lin, L., Huang, L., Chen, F., Wu, K., Lu, P., Zhang, J., & Chou, K. (2004) · Journal of Clinical Immunology · doi:10.1023/b:joci.0000018068.37899.6d · Cited by 5
“In IFN-γ receptor-initiated signal transduction, the role of CIITA protein is also essential in IFNγ induced enhancement of gene activation (17, 18).”
BackgroundRentenaar, R. J., de Metz, J., Bunders, M. J., Dillen, P. M. E. W., Gouma, D. J., Romijn, J. A., Sauerwein, H. P., ten Berge, I. J. M., & van Lier, R. A. W. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01628.x · Cited by 6
Cytomegalovirus Persistence: Escape from Cell-Mediated Immunosurveillance
Miller, D. M., & Sedmak, D. D. (1997) · KARGER eBooks · doi:10.1159/000061684 · Cited by 6
Cissel, D. S., Murty, M. G., Whipkey, D. L., Blaha, J. D., Graeber, G. M., & Keeting, P. E. (1996) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19960201)60:2<260::aid-jcb10>3.0.co;2-r · Cited by 17
Huang, Z.-J., Xu, J., Wang, Y., Fu, Z., Zhang, Y., Zhao, Q., Zhang, R., Hu, X., Cheng, X., & Hu, C. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.105057 · Cited by 12
Cytotoxic CD4+ T cells in cancer: an emerging target for next-generation anticancer immunotherapy?
van Wandeloo, I., Bol, K. F., van Herpen, C., de Vries, I. J., & Schreibelt, G. (2025) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2025-013461 · Cited by 7
Metadata
- Authors
- Steimle, V., Siegrist, C.-A., Mottet, A., Lisowska-Grospierre, B., & Mach, B.
- Affiliations
- University of Geneva (CH)
- Jeantet Laboratory of Molecular Genetics, Department of Genetics and Microbiology, University of Geneva Medical School, CH-1211 Geneva 4, Switzerland.
- INSERM U132, Hôpital des Enfants Malades, 15015 Paris, France.
- Venue
- Science
- Published
- 1994-07
- Volume
- 265
- Issue
- 5168
- Pages
- 106-109
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2060320549
- Cited by
- 898
- References
- 29
- Citations by year
- 2026: 33 · 2025: 35 · 2024: 39 · 2023: 49 · 2022: 35 · 2021: 32 · 2020: 25 · 2019: 20 · 2018: 22 · 2017: 19 · 2016: 27 · 2015: 21 · 2014: 18 · 2013: 13 · 2012: 29
- FWCI
- 13.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- MHC class II expression, interferon-gamma, CIITA, MHC class II deficiency, gene expression regulation, transcriptional activation
- MeSH terms
- Histocompatibility Antigens Class II, Cell Line, Chromosome Mapping, Chromosomes, Human, Pair 16, Fibroblasts, Gene Expression Regulation, Genes, MHC Class II, Humans, Interferon-gamma, Models, Genetic, Nuclear Proteins, RNA, Messenger, Transfection, Tumor Cells, Cultured, Trans-Activators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.